Impel Pharmaceuticals Inc. (NASDAQ:IMPL) Q1 2023 Earnings Call Transcript May 12, 2023
Impel Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-1.27 EPS, expectations were $-0.9.
Operator: Good morning, ladies and gentlemen and welcome to Impel Pharmaceuticals First Quarter 2023 Earnings and Business Update Conference Call. At this time, all participants are in a listen-only mode. Later in this call a question-and-answer session will be conducted and instructions on how...
